Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Urogenital Neoplasms 2Melanoma 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Colitis 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Diarrhea 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Irinotecan 3Theophylline 1Temozolomide 1Oxaliplatin 1Loperamide 1Leucovorin 1Fluorouracil 1Fecal Microbiota Transplantation 1Erlotinib Hydrochloride 1Celecoxib 1Cefpodoxime 1Cefixime 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Diarrhea × Fecal Microbiota Transplantation × Clear all
NCT04038619 2026-03-20

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

M.D. Anderson Cancer Center

Phase 1 Recruiting
40 enrolled
BreastDermatologicGynecologicThoracic

Breast Neoplasms, Uterine Cervical Neoplasms, Colitis, Diarrhea, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Urogenital Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡